- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Astigmatism.
Displaying page 1 of 1.
| EudraCT Number: 2010-021410-34 | Sponsor Protocol Number: EOC-2-Opht-2010 | Start Date*: 2010-08-12 | ||||||||||||||||
| Sponsor Name:Medical Centre Haaglanden | ||||||||||||||||||
| Full Title: A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in children | ||||||||||||||||||
| Medical condition: Depth of cycloplegia; changes of astigmatism; recuperation from cycloplegia and mydriasis | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2015-000268-32 | Sponsor Protocol Number: ZykloTroCyc | Start Date*: 2015-08-12 | |||||||||||
| Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
| Full Title: Prospective, open-label, randomised, single-centre, two-arm, parallel-group, cross-over controlled clinical study, phase 4, to investigate the efficacy of tropicamid 0.5% eyedrops compared to cyclo... | |||||||||||||
| Medical condition: Cycloplegia for objective refraction measurement | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-003373-64 | Sponsor Protocol Number: 01-DIMS-2021 | Start Date*: 2021-11-22 |
| Sponsor Name:NOEMI GUEMES VILLAHOZ | ||
| Full Title: POST-MARKETING PARALLEL CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS AND TOLERABILITY OF DIMS LENSES IN THE CONTROL OF MYOPIA IN PEDIATRIC POPULATION | ||
| Medical condition: MYOPIA IN PEDIATRIC POPULATION | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-003340-37 | Sponsor Protocol Number: PJ21069 | Start Date*: 2018-10-30 | |||||||||||
| Sponsor Name:Technological University Dublin | |||||||||||||
| Full Title: Efficacy and Mechanisms of Low Dose Atropine in the Control of Myopia in Children Trial name: Myopia Outcome Study of Atropine in Children (MOSAIC) | |||||||||||||
| Medical condition: Myopia- a refractive error due to a discrepancy between the anatomical axial length and the focal length of the eye. resulting in distant objects appearing blurred | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: IE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-003976-42 | Sponsor Protocol Number: OT_101_001 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Ocumension (Hong Kong) Limited | ||
| Full Title: A phase III, randomized, double-masked, placebo controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine 0.01%) in treating the progression of myopia in pediatri... | ||
| Medical condition: myopia | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) SK (Trial now transitioned) IE (Trial now transitioned) HU (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004775-13 | Sponsor Protocol Number: SYD-101-001 | Start Date*: 2019-08-02 | |||||||||||
| Sponsor Name:Sydnexis, Inc. | |||||||||||||
| Full Title: A Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children | |||||||||||||
| Medical condition: Myopia | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: SK (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-005017-12 | Sponsor Protocol Number: EyeADHD-01 | Start Date*: 2014-03-31 | |||||||||||
| Sponsor Name:Parnassia Bavo Groep - PsyQ | |||||||||||||
| Full Title: Looking into the eye of ADHD. Investigating the relationship between ADHD, the delayed circadian rhythm and the functioning of the eye. | |||||||||||||
| Medical condition: Adults with ADHD and suboptimal eye functioning. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-001460-11 | Sponsor Protocol Number: 15/0599 | Start Date*: 2016-06-30 | |||||||||||
| Sponsor Name:UCL CCTU | |||||||||||||
| Full Title: Corneal cross-linking versus standard care in children with keratoconus, a randomised, multicentre, observer-masked trial of efficacy and safety | |||||||||||||
| Medical condition: Patients with progressive keratoconus disease | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-002046-16 | Sponsor Protocol Number: MARS_2020 | Start Date*: 2020-11-04 |
| Sponsor Name:Fakultní nemocnice Brno | ||
| Full Title: A Randomised, double-blinded, placebo-controlled, multicenter study of efficacy, safety and side effects of highly diluted atropine collyrium in slowing the progression of myopia (shortsightedness)... | ||
| Medical condition: Myopia in children | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: CZ (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004058-11 | Sponsor Protocol Number: RM-493-023 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Rhythm Pharmaceuticals, Inc. | ||
| Full Title: A Phase 3 trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström syndrome (AS) Patients with Moderate to Severe Obesity | ||
| Medical condition: Obesity and hyperphagia in patients with Bardet-Biedl Syndrome or Alström syndrome | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: FR (Completed) ES (Completed) GB (GB - no longer in EU/EEA) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.